Following completion of this web course, participants should be able to:
Identify risk factors for HCV and recognize barriers for appropriate screening
More effectively diagnose HCV infection
More effectively monitor and manage patients with HCV infection, including HIV-infected patients, those with substance abuse and/or psychiatric conditions, or patients in the prison population.
Recognize and discuss new therapies and appropriate utilization of those therapies including triple drug therapy with protease inhibitors, and future use of oral three drug regimens.
Identify disease management recommendations for patients in accordance with AASLD guidelines, that consider potential barriers to initiation such as socioeconomic status, transportation difficulties in rural areas, and substance abuse and/or psychiatric issues
West Virginia University
Office of Continuing Education
5302 Health Sciences South P.O. Box 9080 Morgantown, WV 26506-9600